Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folivane-OB is a prescription-strength prenatal and postnatal multivitamin and mineral supplement developed and marketed by Trigen Laboratories. It is specifically formulated to meet the increased nutritional requirements of women during pregnancy and the lactation period. The supplement contains a comprehensive blend of essential nutrients, including 1 mg of folic acid to support fetal neural tube development and 85 mg of carbonyl iron to prevent and treat iron deficiency anemia. Carbonyl iron is utilized for its high elemental iron content and improved gastrointestinal tolerability compared to traditional ferrous salts. Additionally, the formulation includes vitamins C, D3, E, B6, and B12, along with minerals such as magnesium, zinc, and copper to support overall maternal and fetal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Folivane-OB.